PGEN

#2147
Precigen, Inc. - Common Stock
4.4 9 USD
-0.44%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
4.42
4.50
Year Range
1.28
5.47
Daily Change
-0.44%
Monthly Change
+9.78%
6 month change
+16.62%
Year Change
+225.36%
Previous Close
4.5 1
Open
4.4 5
Low
4.4 2
High
4.5 0
Volume
521
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 1.6 B
  • Employee 47
  • Founded 1998
  • CEO Helen Sabzevari
  • Website www.precigen.com
  • Headquarter Virginia, United States
  • FIGI BBG000QL8VH9
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents

Precigen, Inc. - Common Stock

Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari. Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells.

News